IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GHEZZI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.314
AS - Asia 5.090
EU - Europa 4.546
Continente sconosciuto - Info sul continente non disponibili 598
SA - Sud America 490
AF - Africa 127
OC - Oceania 33
Totale 16.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.038
SG - Singapore 1.490
CN - Cina 1.439
GB - Regno Unito 1.207
IT - Italia 1.039
BD - Bangladesh 672
DE - Germania 431
HK - Hong Kong 422
SE - Svezia 404
BR - Brasile 370
RU - Federazione Russa 345
VN - Vietnam 332
FR - Francia 242
IN - India 209
CA - Canada 176
NL - Olanda 161
IE - Irlanda 146
FI - Finlandia 125
JP - Giappone 99
KR - Corea 86
ES - Italia 83
DK - Danimarca 82
TR - Turchia 77
ID - Indonesia 63
BE - Belgio 51
PL - Polonia 45
MX - Messico 43
AR - Argentina 38
CI - Costa d'Avorio 37
UA - Ucraina 35
AT - Austria 32
AU - Australia 30
MA - Marocco 30
IQ - Iraq 29
IR - Iran 26
GR - Grecia 22
PK - Pakistan 21
CO - Colombia 17
VE - Venezuela 16
PE - Perù 15
PH - Filippine 15
RO - Romania 15
ZA - Sudafrica 15
UZ - Uzbekistan 14
EC - Ecuador 13
CZ - Repubblica Ceca 12
IL - Israele 11
PT - Portogallo 11
EG - Egitto 10
JM - Giamaica 9
KZ - Kazakistan 9
TW - Taiwan 9
CH - Svizzera 8
CL - Cile 8
CR - Costa Rica 8
JO - Giordania 8
LU - Lussemburgo 8
MY - Malesia 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
NO - Norvegia 7
PR - Porto Rico 7
PY - Paraguay 7
SA - Arabia Saudita 7
DZ - Algeria 6
EU - Europa 6
HN - Honduras 6
NP - Nepal 6
AL - Albania 5
HU - Ungheria 5
RS - Serbia 5
BG - Bulgaria 4
LT - Lituania 4
QA - Qatar 4
SV - El Salvador 4
UY - Uruguay 4
BB - Barbados 3
BH - Bahrain 3
CU - Cuba 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
KE - Kenya 3
MK - Macedonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
Totale 15.583
Salva come PNG Salva come JPEG
Città #
Southend 1.006
Singapore 851
Ashburn 637
Hong Kong 375
San Jose 319
Chandler 303
Milan 301
Council Bluffs 229
Beijing 213
Santa Clara 204
Ann Arbor 192
Fairfield 166
Seattle 165
New York 161
Los Angeles 149
Dublin 137
Princeton 135
Dallas 131
Wilmington 120
Houston 104
Ho Chi Minh City 92
Lauterbourg 86
Buffalo 85
Woodbridge 85
Berlin 77
Guangzhou 77
Hanoi 73
Helsinki 73
Nanjing 73
Bengaluru 69
Hefei 69
Cambridge 67
Toronto 66
Kent 64
Shanghai 64
Moscow 63
Boardman 62
Frankfurt am Main 62
Redwood City 57
Rome 57
The Dalles 57
Naples 55
Tokyo 53
Des Moines 44
Jakarta 44
Phoenix 44
Dearborn 43
Brussels 41
Jinan 40
Abidjan 37
Shenyang 35
Turin 35
Cangzhou 33
Columbus 32
Tianjin 30
London 28
Chicago 25
Ottawa 24
São Paulo 24
Bühl 23
Changsha 23
Istanbul 23
Munich 22
Nanchang 22
Seoul 22
Dong Ket 21
Fuzhou 21
Shenzhen 20
Hangzhou 19
Norwalk 19
Warsaw 19
Athens 18
Montreal 18
Amsterdam 17
Barcelona 17
Central District 17
Nuremberg 17
Redmond 16
Bologna 15
Brescia 15
Haiphong 15
Madrid 15
San Francisco 15
Genoa 14
Rio de Janeiro 14
Vienna 14
Washington 14
Bari 13
Düsseldorf 13
Hebei 13
Mountain View 13
Mumbai 13
Orem 13
Silver Spring 13
Baghdad 12
Tokushima 12
Zhengzhou 12
Atlanta 11
Cagliari 11
Casablanca 11
Totale 8.708
Salva come PNG Salva come JPEG
Nome #
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis? 550
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 542
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 352
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 315
Usefulness of multi-parametric MRI for the investigation of posterior cortical atrophy 307
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status 291
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 291
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis 280
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 270
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis 267
Behavioral and Neurophysiological Effects of Transcranial Direct Current Stimulation (tDCS) in Fronto-Temporal Dementia 267
Causal frontotemporal de generation mutations : a novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 259
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 250
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 249
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients 248
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 248
Validation of the Italian Addenbrooke’s cognitive examination revised (ACE-R) as a screening test 244
Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations 244
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 239
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 239
Circulating miRNAs as potential biomarkers in Alzheimer's disease 236
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes 231
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred 223
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 217
Causal frontotemporal lobar degeneration mutations : a novel mutation in MAPT associated with non-fluent Progressive Aphasia phenotype 216
Alterations of host-gut microbiome interactions in multiple sclerosis 214
A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation 212
Disease-modifying drugs in Alzheimer's disease 210
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 209
UNRAVELLING THE ROLE OF MUCOSAL ASSOCIATED INVARIANT T CELLS IN THE PATHOGENESIS OF MULTIPLE SCLEROSIS AND ITS ANIMAL MODEL 209
Inflammatory molecules in Frontotemporal Dementia : Cerebrospinal fluid signature of progranulin mutation carriers 203
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with alzheimer's disease 202
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred 200
A “glympse” into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin‐4 for the assessment of glymphatic system in Alzheimer's disease and other dementias 199
Sciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathy 196
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation 188
GRN Asp22fs mutation is associated with highly variable age at onset, clinical phenotype and brain atrophy 185
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease 185
Why Is Multiple Sclerosis More Frequent in Women? Role of the Immune System and of Oral and Gut Microbiota 184
Early onset behavioral variant frontotemporal Dementia due to the C9ORF72 Hexanucleotide Repeat Expansion: Psychiatric Clinical Presentations 184
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 182
Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod 181
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy 180
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 178
The impact of osteopontin gene variations on multiple sclerosis development and progression 174
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 173
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 169
The influence of hormonal contraception on depression and female sexuality: a narrative review of the literature 167
Phenotypic heterogeneity of the progranulin gene Asp22fs mutation in a large Italian kindred 166
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 161
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis [Low CSF beta-amyloid levels predict early regional grey matter atrophy in multiple sclerosis] 160
Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota 156
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome 156
The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases 153
Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia − A GENFI study 152
GRN Asp22fs mutation is associated with heterogeneous neurodegenerative clinical phenotypes 150
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration 141
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration 139
Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation 137
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 136
A case of vanishing white matter disease due to the c.260C > T(p.Ala87Val) EIF2B3 mutation 130
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 128
Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity 123
Immunotherapy against amyloid pathology in Alzheimer's disease 123
Frequency of the C9ORF72 hexanucleotide repeat expansion in Italian non demented elderly subjects 122
A case of vanishing white-matter disease due to the c.260C>T (p.Ala87Val) EIF2B3 mutation 118
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study 118
T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients 118
Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease 115
Causal frontotemporal degeneration mutations : a novel MAPT mutation associated with clinical phenotype of progressive nonfluent aphasia 107
CSF sphingolipids are correlated with neuroinflammatory cytokines and differentiate neuromyelitis optica spectrum disorder from multiple sclerosis 104
Association between Klotho levels in cerebrospinal fluid and choroid plexus enlargement in neurodegeneration 100
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis 100
Alzheimer's disease: Clinical aspects and treatments 99
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases 98
Two cases of early onset FTLD due to chromosome 9 hexanucleotide repeats 94
From diagnosis to disease staging: multisite validation of cerebrospinal fluid molecular tests in multiple sclerosis 92
Frequency of autosomal dominant mutations in an Italian population of patients with frontotemporal lobar degeneration 91
Cognitive predictors and correlations with biomarkers and functional imaging in patients with primary progressive aphasia 90
Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction 89
Energy restriction in people with multiple sclerosis: Is time more important than calories? 89
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis 88
Schwann cell remyelination in the multiple sclerosis central nervous system 86
Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients 84
Frequency of autosomal dominant mutations in an Italian population of patients with frontotemporal lobar degeneration 75
Targeting the gut to treat multiple sclerosis 73
Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative diseases 73
Alterations of the gut mycobiome in patients with MS 70
Diagnosis of alzheimer’s disease typical and atypical forms 68
The serum lipid profile of relapsing multiple sclerosis differs reproducibly from healthy controls 67
Totale 16.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022776 0 0 33 37 46 58 77 89 104 81 82 169
2022/20231.310 152 156 107 129 124 243 41 84 127 27 85 35
2023/20241.024 34 74 68 72 227 60 73 90 45 68 98 115
2024/20252.610 51 293 79 235 192 108 156 243 129 271 219 634
2025/20265.735 544 313 446 447 433 297 665 245 610 375 841 519
2026/2027736 391 345 0 0 0 0 0 0 0 0 0 0
Totale 16.198